Article Index

May 2006

Why the Data Diverge on the Dangers of Vioxx
Vioxx-Linked Heart Attacks May Occur Within 2 Weeks, Study Says

April 2006

the popular arthritis and painkilling drug celecoxib (CELEBREX) may double the risk for heart attacks
Study Shows How Painkillers Raise Heart Risk
Suit Alleges Merck Negligently Promoted Osteoporosis Drug Fosamax

July 2005

At Vioxx Trial, a Discrepancy Appears to Undercut Merck's Defense

March 2005

PRETRIAL PROCESS FOR VIOXX LITIGATION BEGINS

February 2005

Wife's Vioxx death drives local man to lobby against tort reform
L.A. judge removed from painkiller lawsuit case
FDA Improvements in Drug Safety Monitoring ????
There is unfortunate breaking news that the FDA Panel has approved the return of Vioxx to the market by a vote of 17-15, strongly favored keeping Celebrex on the market, and split over Bextra remaining on market. While the panel's recommendations are
Federalizing Class Actions Protects Negligent Drug Makers and Hurts Vioxx Victims
The FDA Excuse: Medical Malpractice Proposals Give Drug Companies a Pass for Selling Dangerous Products
FDA OKs Medicis Drug for Combo Therapy
Naproxen Warning Unjustified, Say FDA Experts
FDA Panel Says Celebrex Should Stay
Your Keyword News Alert for [FDA drug recall]
Beasley Allen Calls Upon Merck to Leave Vioxx Off the Market
U.S. Court in Louisiana to Handle Vioxx Cases
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Local Man Files Lawsuit Against Makers Of Vioxx
'My Wife's Life Was Not Frivolous': Vioxx Hurts Real People
CONYERS MEDICAL MALPRACTICE VICTIMS FORUM WEBCAST
Call on President Bush to Preserve Their Freedom and Liberty to Keep the Right to Access the Judicial System

January 2005

Federal judges discuss Vioxx lawsuits
STUDY BY VIOXX CRITIC LINKS DRUG TO EXTRA CORONARY CASES
Researchers: Merck Discredited Initial Vioxx Findings
Hundreds of Lawyers Gather at LexisNexis-Sponsored Symposium On Vioxx to Discuss Recent Developments in the Legal Drive Against Merck
Bravado Could Come Back to Haunt Pfizer
Dimethaid intends to fill Vioxx void
Painkiller alerts give alternatives a boost
Ruling on arthritis drugs awaited
White House Trying to Squelch Consumer Protection by Limiting Court Access, Says Coalition to Preserve Access to Justice
Drug Industry admits that we did not get all of the data...
VP Pleads Guilty In Marsh Case
Will Bush Use GOP Pollster Luntz's Scare Tactics & Lies To Seek Limited Accountability For Medical Establishment?
Todd A. Smith President Association of Trial Lawyers of America speaks out against Bushg Malpractice Plan
Bush Using 'Capital' to Push Malpractice Reform Legislation
Blogwise Vioxx Blogs
BAD MEDICINE with David Brancaccio
When the FDA is weak, we rely on strong courts.
Drug Companies Lagging on Openness
Safety should come before marketing
FDA approach tough pill for critics
Study Shows Different Heart Effects of COX Drugs
DNA Tests Now Available Reveal Possible Deadly Side Effects; Genelex Urges Users of Vioxx, Bextra, Celebrex, Aleve and Others to Check DNA Before Taking Meds
Vioxx: More Debate, More Data

December 2004

Lawsuit Filed Soon After Scott's Filing of Merck Case
Top Executive at Merck CEO Might Expected in March Over Vioxx Lawsuits
No healing in sight for ailing drug industry
Pfizer Likely to Survive Skid in Celebrex Sales
Vioxx Case Illustrates Dual Nature of Drugs Researchers Also Discover Positive Side
Vioxx Case Illustrates Dual Nature of Drugs
Hope plaintiffs want Vioxx suit moved back to county
Bill would shield some drug firms from punitive damages
Painkillers set to become the new wave in American courts
Drug Puzzle: When Do Risks Outweigh Benefits?
Merck had knowledge of the dangers of Vioxx
Pfizer Halts 2 Celebrex Trials After 1 Shows Increased Cardiovascular Risk
OPINION: WITHOUT LAWYERS, RIGHTS MEAN NOTHING
ATLA PRESS RELEASE: BUSH ECONOMIC SUMMIT PLAN: TAKE AWAY AMERICANS' LEGAL RIGHTS
The Drugmaker Won't Even Guesstimate Its Vioxx Legal Bill -- Or Discuss The Hunt For A New CEO, Who Will Face The Debacle's Financial Fallout
Tough Times Ahead for Cox-2 Inhibitors
Merck to Cut 5,100 Jobs by End of Year
Merck CEO Goes On Defense, Cuts Jobs
Arizona Consumer Files First Class Action Against Vioxx Manufacturer Merck
FDA Launches Vioxx Drug Center on the Web.
Sixty percent of Vioxx users concerned that their or a family member's health might be negatively affected by taking the drug
Hundreds of affected consumers are now bringing cases against Merck, the maker of Vioxx.
CELEBREX MAY NOT CARRY RISK OF HEART ATTACKS
AT F.D.A., STRONG DRUG TIES AND LESS MONITORING
Congress members demand answers from FDA about whistle-blower
Lawmaker claims FDA pressured safety official not to act on Vioxx
Australian claims for damages caused by Vioxx
A.M.A. SEEKS MORE OPENNESS IN DRUG TRIALS
Killer Quotes about Vioxx
Vioxx was approved for kids... if you can believe that.
The Pharmaceutical Drug Cartel and the FDA by Jack Kettler
Dr Bob's Newsletter - November 2004 by Robert Roy MD
Timeline of what Merck knew about Vioxx

October 2004

How big a "blockbuster" was Vioxx for Merck?

September 2004

Merck Announces Voluntary Worldwide Withdrawal of VIOXX?